These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort. Vavricka SR; Rogler G; Gantenbein C; Spoerri M; Prinz Vavricka M; Navarini AA; French LE; Safroneeva E; Fournier N; Straumann A; Froehlich F; Fried M; Michetti P; Seibold F; Lakatos PL; Peyrin-Biroulet L; Schoepfer AM Inflamm Bowel Dis; 2015 Aug; 21(8):1794-800. PubMed ID: 26020601 [TBL] [Abstract][Full Text] [Related]
4. The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients. Roth R; Vavricka S; Scharl M; Schreiner P; Safroneeva E; Greuter T; Zeitz J; Misselwitz B; Schoepfer A; Barry MP; Rogler G; Biedermann L; United European Gastroenterol J; 2021 Sep; 9(7):773-780. PubMed ID: 34431613 [TBL] [Abstract][Full Text] [Related]
5. The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease. King D; Chandan JS; Thomas T; Nirantharakumar K; Reulen RC; Adderley NJ; Trudgill N Inflamm Bowel Dis; 2021 Oct; 27(11):1731-1739. PubMed ID: 34669933 [TBL] [Abstract][Full Text] [Related]
6. Smoking increases the risk of extraintestinal manifestations in Crohn's disease. Ott C; Takses A; Obermeier F; Schnoy E; Müller M World J Gastroenterol; 2014 Sep; 20(34):12269-76. PubMed ID: 25232261 [TBL] [Abstract][Full Text] [Related]
7. Severe Disease Activity Based on the Paris Classification Is Associated with the Development of Extraintestinal Manifestations in Korean Children and Adolescents with Ulcerative Colitis. Jang HJ; Suh HR; Choi S; Hong SJ; Cho SM; Choi KH; Choe BH; Kang B; J Korean Med Sci; 2021 Nov; 36(44):e278. PubMed ID: 34783212 [TBL] [Abstract][Full Text] [Related]
8. Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel Disease. Dubinsky MC; Cross RK; Sandborn WJ; Long M; Song X; Shi N; Ding Y; Eichner S; Pappalardo B; Ganguli A; Wang A Inflamm Bowel Dis; 2018 Aug; 24(9):1876-1882. PubMed ID: 29668916 [TBL] [Abstract][Full Text] [Related]
9. [Incidence and risk factors of extraintestinal manifestations in children with inflammatory bowel disease]. Shan CY; Zhang QQ; Xiao Y; Wang XQ; Yu Y; Xu X; Xu CD Zhonghua Er Ke Za Zhi; 2019 Sep; 57(9):694-699. PubMed ID: 31530355 [No Abstract] [Full Text] [Related]
10. Clinical Features Focusing on Extraintestinal Manifestations in Japanese Patients with Inflammatory Bowel Diseases: Far East 1000. Ohta Y; Taida T; Kato J; Ogasawara S; Oyama Y; Mamiya Y; Nakazawa H; Horio R; Goto C; Takahashi S; Kurosugi A; Sonoda M; Shiratori W; Kaneko T; Yokoyama Y; Akizue N; Ishigami H; Koseki H; Okimoto K; Saito K; Saito M; Matsumura T; Nakagawa T; Masuya Y; Fukuda Y; Kitsukawa Y; Shimura H; Tsuyuguchi T; Kato N Digestion; 2023; 104(4):328-334. PubMed ID: 36893744 [TBL] [Abstract][Full Text] [Related]
11. Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity. Dotson JL; Hyams JS; Markowitz J; LeLeiko NS; Mack DR; Evans JS; Pfefferkorn MD; Griffiths AM; Otley AR; Bousvaros A; Kugathasan S; Rosh JR; Keljo D; Carvalho RS; Tomer G; Mamula P; Kay MH; Kerzner B; Oliva-Hemker M; Langton CR; Crandall W J Pediatr Gastroenterol Nutr; 2010 Aug; 51(2):140-5. PubMed ID: 20453677 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel Disease. Khrom M; Long M; Dube S; Robbins L; Botwin GJ; Yang S; Mengesha E; Li D; Naito T; Bonthala NN; Ha C; Melmed G; Rabizadeh S; Syal G; Vasiliauskas E; Ziring D; Brant SR; Cho J; Duerr RH; Rioux J; Schumm P; Silverberg M; Ananthakrishnan AN; Faubion WA; Jabri B; Lira SA; Newberry RD; Sandler RS; Xavier RJ; Kugathasan S; Hercules D; Targan SR; Sartor RB; Haritunians T; McGovern DPB Gastroenterology; 2024 Jul; 167(2):315-332. PubMed ID: 38490347 [TBL] [Abstract][Full Text] [Related]
14. Risk Factors for Extraintestinal Manifestations in Inflammatory Bowel Diseases - Data from the Romanian National Registry. Singeap AM; Girleanu I; Diculescu M; Gheorghe L; Ciocîrlan M; Gheorghe C; Costache A; Tanțău A; Zaharie R; Goldis A; Gheonea D; Dobru D; Dumitru E; Prelipcean CC; Gîlcă-Blanariu GE; Moscalu M; Stanciu C; Trifan A J Gastrointestin Liver Dis; 2021 Sep; 30(3):346-357. PubMed ID: 34375380 [TBL] [Abstract][Full Text] [Related]
15. Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study. Vavricka SR; Gubler M; Gantenbein C; Spoerri M; Froehlich F; Seibold F; Protic M; Michetti P; Straumann A; Fournier N; Juillerat P; Biedermann L; Zeitz J; Misselwitz B; Scharl M; Heinrich H; Manser CN; Safroneeva E; Raja Ali RA; Rogler G; Schoepfer AM; Greuter T; Inflamm Bowel Dis; 2017 Jul; 23(7):1174-1181. PubMed ID: 28452862 [TBL] [Abstract][Full Text] [Related]
16. Extraintestinal manifestations of inflammatory bowel disease and intestinal tuberculosis: Frequency and relation with disease phenotype. Singh B; Kedia S; Konijeti G; Mouli VP; Dhingra R; Kurrey L; Srivastava S; Pradhan R; Makharia G; Ahuja V Indian J Gastroenterol; 2015 Jan; 34(1):43-50. PubMed ID: 25663290 [TBL] [Abstract][Full Text] [Related]
17. Extraintestinal Manifestations of Inflammatory Bowel Disease in Middle Eastern Patients. Adam H; Alqassas M; Saadah OI; Mosli M J Epidemiol Glob Health; 2020 Dec; 10(4):298-303. PubMed ID: 32959603 [TBL] [Abstract][Full Text] [Related]
18. Extraintestinal manifestations of inflammatory bowel disease and the influence of smoking. Roberts H; Rai SN; Pan J; Rao JM; Keskey RC; Kanaan Z; Short EP; Mottern E; Galandiuk S Digestion; 2014; 90(2):122-9. PubMed ID: 25277851 [TBL] [Abstract][Full Text] [Related]
19. Extraintestinal manifestations in inflammatory bowel disease: Prevalence and predictors in Indian patients. Bandyopadhyay D; Bandyopadhyay S; Ghosh P; De A; Bhattacharya A; Dhali GK; Das K Indian J Gastroenterol; 2015 Sep; 34(5):387-94. PubMed ID: 26614005 [TBL] [Abstract][Full Text] [Related]
20. Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort. Tadbiri S; Peyrin-Biroulet L; Serrero M; Filippi J; Pariente B; Roblin X; Buisson A; Stefanescu C; Trang-Poisson C; Altwegg R; Marteau P; Vaysse T; Bourrier A; Nancey S; Laharie D; Allez M; Savoye G; Gilletta C; Gagniere C; Vuitton L; Viennot S; Aubourg A; Pelletier AL; Bouguen G; Abitbol V; Fumery M; Claudepierre P; Bouhnik Y; Amiot A; Aliment Pharmacol Ther; 2018 Feb; 47(4):485-493. PubMed ID: 29250803 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]